When retatrutide triggers this receptor, fat from the liver and other stores gets broken down and burned as fuel
You should be consulted in detail in order to evaluate your eligibility and to check your safety during the treatment course
In the ATTAIN-2 trial including those with T2D and HbA1c of 710%, at week 72, weight loss reached 5.1%, 7%, 9.6% and HbA1c decreased by 1.22%, 1.50%, 1.66% with orforglipron 6 mg, 12 mg, 36 mg, compared to 2% and 0.47% with placebo, respectively [62]
Avoid high-fat, greasy, and heavily seasoned foods during the first few weeks at each new dose level
It is educational product content with clear, responsible claim boundaries and links to bottle options, comparisons, and support
Nat Commun 8:15201